ERBB2 and breast cancer: Because the present study was aimed at demonstrating the efficiency of HER2‐targeted NIR‐PIT in HER2‐positive breast cancer, we had to fix the time point of the histological assessment of tumors after irradiation and we could demonstrate diffuse necrosis 1 day after NIR‐PIT.